Transient Erythroblastopenia of ChildhoodSymptoms, Doctors, Treatments, Advances & More
Learn About Transient Erythroblastopenia of Childhood
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Johns Hopkins All Children's Outpatient Care, Tampa
Adrianna Vlachos is a Hematologist and a Pediatric Hematologist Oncology provider practicing medicine in Tampa, Florida. Dr. Vlachos is rated as an Elite provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Aase Syndrome, Pure Red Cell Aplasia, Aplastic Anemia, and Transient Erythroblastopenia of Childhood. Dr. Vlachos is board certified in American Board Of Pediatrics. Dr. Vlachos is currently accepting new patients.
Northwell Health Pediatric Hematology/Oncology & Stem Cell Transplant
Jeffrey Lipton is a Pediatric Hematologist Oncology provider practicing medicine in New Hyde Park, New York. Dr. Lipton is rated as an Elite provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Aase Syndrome, Pure Red Cell Aplasia, Transient Erythroblastopenia of Childhood, Aplastic Anemia, and Bone Marrow Transplant. Dr. Lipton is board certified in American Board Of Pediatrics. Dr. Lipton is currently accepting new patients.
Lydie Da Costa practices practicing medicine in Paris, France. Ms. Da Costa is rated as an Elite expert by MediFind in the treatment of Transient Erythroblastopenia of Childhood. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Pure Red Cell Aplasia, Aase Syndrome, Transient Erythroblastopenia of Childhood, Splenectomy, and Bone Marrow Transplant.
Background: A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders. Pathogenic variant(s) in IBMFS genes are relevant to carcinogenesis in sporadic cancers. Patients with IBMFS who develop cancer differ in their genetic and/or environmental features from patients with IBMFS who do not develop cancer. These cancer-...
Summary: The purpose of this study is to evaluate what effect, if any, mismatched unrelated volunteer donor and/or haploidentical related donor stem cell transplant may have on severe sickle cell disease and other transfusion dependent anemias. By using mismatched unrelated volunteer donor and/or haploidentical related donor stem cells, this study will increase the number of patients who can undergo a stem...